The first appearance of CJC-1295 DAC was in 2005, presented by the Canadian biotechnology company ConjuChem. Unlike the peptides of the GHRP group, CJC-1295 DAC releases growth hormone evenly in small amounts without sharp jumps in GH in the blood and has similar effects to growth hormone. After a single injection of CJC-1295 DAC, the concentration of the hormone in the blood increases by 2-10 times within six days. Used by the athletes for various purposes of performance enhancement.

Effects:

By using CJC-1295 DAC athletes can increase muscle gains and performance and get rid of unwanted fat. Additionally, it raises collagen synthesis for tendons and ligament reinforcement and overall body wellbeing.

Side-Effects:

CJC-1295 DAC is a peptide and does not result in adverse reactions associated with anabolic steroids. The most common adverse reactions attributed to the CJC-1295 DAC are excessive water retention and weakness.